Targeting autophagy with small-molecule activators for potential therapeutic purposes

Area of Science:

• Cell Biology
• Molecular Medicine
• Drug Discovery

Background:

• Autophagy is a vital lysosome-mediated catabolic process essential for maintaining cellular and organismal homeostasis.
• Defects in autophagy are implicated in the pathogenesis of numerous human diseases.
• Activating autophagy presents a potential therapeutic avenue, contrasting with inhibition strategies.

Purpose of the Study:

• To summarize the complex relationship between defective autophagy and human diseases.
• To review recent advancements in small-molecule activators targeting autophagy for therapeutic applications.
• To provide insights for developing novel autophagy-activating drugs.

Main Methods:

• Literature review and synthesis of research on autophagy and its role in disease.
• Analysis of small-molecule compounds designed to activate autophagy.
• Discussion of current therapeutic strategies and future directions.

Main Results:

• Established links between impaired autophagy and various human pathologies.
• Identification and categorization of small-molecule autophagy activators.
• Overview of the therapeutic potential of these activators in disease contexts.

Conclusions:

• Activating autophagy is a viable therapeutic strategy for diseases associated with autophagy dysfunction.
• Small-molecule activators represent promising candidates for targeted drug development.
• Further research into autophagy modulation could lead to novel treatments for human diseases.